Cluster Headaches are accepted to be because of a blend of ecological and hereditary components. Around 66% of cases keep running in families. Changing hormone levels might likewise assume a part, as headaches influence marginally a bigger number of young men than young ladies before pubescence, yet around a few times a larger number of ladies than men.
All inclusive, around 15% of the populace is influenced by headaches sooner or later in life. Of 598 patients screened, 441 questionnaires were analysed (79 % female, mean age 41.1 years). According to the Eurolight algorithm, 56.4 % of the patients had EH, 38.3 % had Cluster Headche and 5.2 % did not give their cluster headache frequency. The prevalence rates of cluster headache was 15.9 %. The number of cluster headache cases are increasing day by day.
These types of drugs are taken regularly, often on a daily basis, to reduce the severity or frequency of cluster headaches. The FDA is currently reviewing a new migraine drug called Trexima, which combines the migraine drug Imitrex (sumitriptan) and naproxen sodium (a nonsteroidal anti-inflammatory drug) contained in Aleve and other over-the-counter medications.